SCHEMBL4287947

SCHEMBL4287947

CO[C@H]1O[C@H](COC(=O)c2ccccc2)[C@@](C)(OC)[C@H](OC(=O)c2ccccc2)[C@H]1OC(=O)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
MEN1 O00255 1/20 0.38
USP2 O75604 1/20 0.38
POLB P06746 1/20 0.38
KMT2A Q03164 1/20 0.38
NPC1 O15118 1/20 0.37
CES2 O00748 1/20 0.37
MAPT P10636 1/20 0.37
LGALS3 P17931 2/20 0.36
LGALS4 P56470 1/20 0.36
ABCB1 P08183 5/20 0.35
LGALS9 O00182 1/20 0.35
LGALS1 P09382 1/20 0.35
LGALS7; LGALS7B P47929 1/20 0.35
PTPN1 P18031 1/20 0.35
GAA P10253 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
CHRNB2 P17787 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4284504 0.91 ALDH1A1 (0.41) ALDH1A1MEN1USP2POLBKMT2A
SCHEMBL4287942 0.88 ALDH1A1 (0.44) ALDH1A1MEN1USP2POLBKMT2A
SCHEMBL1720756 0.87 ALDH1A1 (0.41) ALDH1A1MEN1USP2POLBKMT2A
SCHEMBL1720755 0.87 ALDH1A1 (0.42) ALDH1A1MEN1USP2POLBKMT2A
SCHEMBL14615426 0.84 ALDH1A1 (0.45) ALDH1A1MEN1USP2POLBKMT2A
SCHEMBL15414470 0.84 ALDH1A1 (0.45) ALDH1A1MEN1USP2POLBKMT2A
SCHEMBL13649179 0.84 ALDH1A1 (0.45) ALDH1A1MEN1USP2POLBKMT2A
SCHEMBL8818204 0.83 ALDH1A1 (0.38) ALDH1A1MEN1USP2POLBKMT2A
SCHEMBL7901701 0.83 ALDH1A1 (0.38) ALDH1A1MEN1USP2POLBKMT2A
SCHEMBL7901705 0.81 ALDH1A1 (0.37) ALDH1A1MEN1USP2POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 ALDH1A1 896/4885MEN1 3776/4885USP2 4135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.